Related Experiment Videos
Emerging drugs for ichthyosis.
1University of Maastricht, Department of Dermatology, University Hospital Maastricht and GROW Research School, PO Box 5800, 6202 AZ Maastricht, The Netherlands. mauricevansteensel@gmail.com
Expert Opinion on Emerging Drugs
|November 6, 2007
Summary
New treatments for ichthyosis, a group of skin disorders causing scaling, are emerging. Retinoic acid metabolism blocking agents (RAMBAs) offer potential for effective treatment with fewer side effects than traditional retinoids.
Area of Science:
- Dermatology
- Genetics
- Pharmacology
Background:
- Ichthyoses are a diverse group of genetic skin disorders characterized by scaling.
- Current treatments include topical agents and oral retinoids, but these have limitations.
- Retinoids are effective but associated with significant side effects and teratogenicity.
Purpose of the Study:
- To review retinoic acid metabolism blocking agents (RAMBAs) for ichthyosis treatment.
- To discuss RAMBAs currently in clinical trials.
- To explore future therapeutic developments for ichthyosis.
Main Methods:
- Literature review of current and emerging ichthyosis treatments.
- Focus on retinoic acid metabolism blocking agents (RAMBAs).
- Analysis of clinical trial data and potential future applications.
Main Results:
- RAMBAs represent a novel therapeutic approach for ichthyosis.
- These agents aim to enhance retinoid efficacy while mitigating side effects.
- RAMBAs may offer a reduced teratogenicity period compared to traditional retinoids.
Conclusions:
- RAMBAs show promise for improved ichthyosis management.
- Further clinical trials are necessary to establish safety and efficacy.
- This class of drugs could represent a significant advancement in treating ichthyosis.
Related Concept Videos
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:23Hand hygiene
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...